Hantavirus infection and biodiversity in the Americas

Vadell, María Victoria; Villafañe, Isabel E. Gómez; Carbajo, Aníbal Eduardo

doi:10.1007/s00442-019-04564-0

Cited by 25 publications

(17 citation statements)

References 70 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Sin embargo, aún no se ha comprobado que existe relación entre la teoría del efecto de dilución y la prevalencia en el nuevo mundo. [7] Nuevos reportes de casos de SPH demuestran su presencia fuera de las Américas. En 2016, Alemania describe un caso por PUUV que evolucionó con síndrome de insuficiencia respiratoria aguda, progresó a falla circulatoria y requirió oxigenación por membrana extracorpórea, siendo estas manifestaciones del SPH.…”

Section: Antecedentesunclassified

Síndrome Pulmonar por Hantavirus: un artículo de revisión

2021

View full text Add to dashboard Cite

ANTECEDENTES: El síndrome pulmonar por hantavirus es ocasionado por el virus del orden Bunyavirales, familia Hantaviridae. Descrito por primera vez en un brote de casos en Estados Unidos en 1993 y actualmente con más de quince serotipos en América. Tiene una alta mortalidad y prevalencia variable; transmitido por roedores que, por los cambios climáticos y los movimientos migratorios, tienen más contacto con el ser humano. Presenta tropismo endotelial por el sistema respiratorio, con hallazgos de infiltrados pulmonares y trombocitopenia, desarrollando en pocos días un edema pulmonar no cardiogénico y choque. No se cuenta actualmente con tratamiento específico ni vacuna. OBJETIVO: Exponer el origen del síndrome pulmonar, comprender su epidemiología, fisiopatología, manifestaciones, investigar sobre los métodos diagnósticos y posibles tratamientos. DISEÑO: Utilizamos los motores de búsqueda Pubmed, Cochrane, Science Direct y Scielo; delimitando artículos científicos publicados en inglés y español. Recopilando 148 publicaciones entre reporte de casos, estudios observacionales y experimentales, la mayoría entre los años 2010 y 2020. CONCLUSIÓN: Las infecciones por hantavirus son diversas, donde progresivamente hemos podido entender su evolución, reservorios, formas de contagio, factores de riesgo, distribución mundial y las principales áreas endémicas para desarrollar estrategias de salud pública. No solo es una enfermedad zoonótica, sino también una enfermedad emergente que requiere atención multidisciplinaria para el implemento de nuevas terapias.

show abstract

Section: Antecedentesunclassified

Síndrome Pulmonar por Hantavirus: un artículo de revisión

2021

View full text Add to dashboard Cite

show abstract

“…Numerous studies have used mediation analysis to investigate whether there is a causal pathway between infectious disease agents and the level of biodiversity (genetic, phenotypic and species diversity of vectors/hosts, functional diversity for vector and reservoir competence) (Ostfeld, 2009;Roberts and Heesterbeek, 2018;Vadell, Gómez Villafañe and Carbajo, 2020). Evidence has been found for both the dilution hypothesis (increased biodiversity causes a decreased VBD prevalence; zooprophylaxis; e.g.…”

Section: Exposure To Infectious Agents Causing Human Diseasesmentioning

confidence: 99%

“…But very often, no or weak relationships between biodiversity measures and VBD prevalence were detected (e.g. Stensgaard et al, 2016;Ruyts et al, 2018;Vadell, Gómez Villafañe and Carbajo, 2020). Certainly, the enormous complexity in biodiversity-healthenvironment interactions at local to global level is a major challenge when designing VBD prevention and vector control strategies.…”

Section: Exposure To Infectious Agents Causing Human Diseasesmentioning

confidence: 99%

Pathways linking biodiversity to human health: A conceptual framework

Marselle¹,

Hartig²,

Cox³

et al. 2020

Preprint

View full text Add to dashboard Cite

Biodiversity is a cornerstone of human health and well-being. However, while evidence of the contributions of nature to human health is rapidly building, understanding of how biodiversity relates to human health remains limited in important respects. In particular, we need a better grasp on the range of pathways through which biodiversity can influence human health, including those that run through psychological and social processes as well as through biochemical and biophysical processes. Building on evidence from across the natural, social and health sciences, we present a conceptual framework organising the pathways linking biodiversity to human health. Four domains of pathways—both beneficial as well as harmful—link biodiversity with human health: (i) reducing harm (e.g. provision of medicines, decreasing exposure to air and noise pollution); (ii) restoring capacities (e.g. attention restoration and stress reduction); (iii) building capacities (e.g. promoting physical activity, transcendental experiences), and (iv) causing harm (e.g. dangerous wildlife, zoonotic diseases or allergens). We discuss how to test components of the biodiversity-health framework with analytical approaches and existing datasets. In a world with accelerating declines in biodiversity, profound land-use change, and an increase in non-communicable and zoonotic diseases globally, greater understanding of these pathways can reinforce biodiversity conservation as a strategy for the promotion of health for both people and nature. We conclude by identifying research avenues and recommendations for policy and practice to foster biodiversity-focused public health actions.

show abstract

“…宿主生物多样性与传染性疾病(以下简称"疾病")风险之间存在着千丝万缕的联系 (Wood et al, 2014;Rohr et al, 2020)。在生物多样性大规模丧失的背景下 (Pimm et al, 2014) (Elton, 1958) (Ostfeld & Keesing, 2000;LoGiudice et al, 2003) 、西尼罗河病毒 (Kilpatrick et al, 2006)、两栖类吸虫病 (Johnson et al, 2013b)、大麦黄矮病毒 (Lacroix et al, 2014)和叶片真菌病害 (Mitchell et al, 2002;Rottstock et al, 2014;Liu et al, 2016)等疾病的系统性研究, 生态学家已证实稀释效应在部分系统中确实存在; 并相应地总结出了稀释效应发生的潜在机制 (Keesing et al, 2010;Ostfeld & Keesing, 2012)。然而 , 生物多样性与疾病之间的关系可能具有较强的体系依赖性 ; 部分研究证实无效应 (Salkeld et al, 2013;Vadell et al, 2020)甚至放大效应 (Wood et al, 2014;Halliday et al, 2017)在自然界中也同样存在。另一方面, 也有学者认为目前学界过度关注稀释效应发生的普遍性 (Randolph & Dobson, 2012; Bever JD (1994) Feedback between plants and their soil communities in an old field community. Ecology, 75, 1965-1977.…”

Section: 综述unclassified

The relationship between biodiversity and infectious disease: Progress, challenge and perspective

Liu¹,

Chen²,

Zhou³

2020

Biodiversity Science

View full text Add to dashboard Cite

Current unprecedented declines in biodiversity have galvanized efforts to understand how changes in biodiversity affect disease risk. Empirical evidence is mixed in understanding the relationship between loss in biodiversity and disease. While some empirical research supports a dilution effect (i.e., disease risk decreases with increasing host biodiversity), many studies support an amplification effect, and in some cases no effect. In this review, we first summarize the research progresses in this area, and introduce key research topics that include: the shape of the biodiversity-disease relationship, spatial-and context dependence of dilution effect, and the phylogenetic dilution effect. Following our summary, we discuss the disputes and criticisms in this field of research. These controversies include: whether the dilution effect is prevalent, publication bias in experimental studies, and an excessive focus by some disease ecologists on the numeric relationship between biodiversity and disease. Finally, we highlight some open questions for future research looking at dilution effect that include: the relationship between dilution effect and species coexistence, the effects of global climate change on dilution effect, the relationship between dilution effect and evolution, and the implications this research can have on policy decisions.

show abstract

Hantavirus infection and biodiversity in the Americas

Cited by 25 publications

References 70 publications

Síndrome Pulmonar por Hantavirus: un artículo de revisión

Síndrome Pulmonar por Hantavirus: un artículo de revisión

Pathways linking biodiversity to human health: A conceptual framework

The relationship between biodiversity and infectious disease: Progress, challenge and perspective

Contact Info

Product

Resources

About